Back

Pri-Med Institute

  • Alopecia
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Obesity

GLP-1 RAs and Hair Loss Evaluating and Managing a Potential Side Effect – Frankly Speaking Ep 478

As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) become increasingly common in managing obesity, it is important for clinicians to recognize lesser-known adverse effects. This episode highlights the potential link between GLP-1 RAs and alopecia, equipping you to better evaluate, counsel, and manage patients reporting hair loss.Episode references and resource links: Alsuwailem OA, Alanazi R, Almutairi HM, Asiree RH, Almutairi W, Almutairi TM, Zamandar A, Alkhames S. Hair Loss Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use: A Systematic Review. Cureus. 2025 Sep 16;17(9):e92454. The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.25 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes Article / monograph / reference
  • Credit · Up to 0.25 credits
  • Released
    Mar 30, 2026
  • Last day to claim credit
    Apr 1, 2028 1 year left